Did FDA's Pain Med Warning Scare Shionogi Away From Victory?

Has Victory been turned into defeat? The abrupt and mysterious evaporation of Shionogi's plans to buy Victory Pharma for $150 million is fueling speculation that Japanese pharma got cold feet about the deal, possibly because of FDA's shifting policy on pain products

More from Archive

More from Scrip